What's on this Page
Can contrast enhanced MRI be done in patients with CKD?
• Yes. Early-generation, linear gadolinium agents are the only ones in which NSF was reported. The newer cyclical agents bind gadolinium more tightly and are approved down to an eGFR of 30 mL/min per 1.73m 2 .
Most of these new agents have no documented cases of NSF, even in patients with eGFR below 30 mL/min per 1.73 m 2 or with dialysis (per some studies).
Gadolinium Based MRI Contrast Agents
Name | Trade Name | Molecular Structure | Type | NSF Reported |
---|---|---|---|---|
Gadotate | Dotarem | Macrocyclic ionic | Extracellular a | No |
Gadodiamide | Omniscan | Linear ionic | Extracellular | Yes |
Gadopentetate | Magnevist | Linear ionic | Extracellular | Yes |
Gadobenate | Multihance | Linear ionic | Extracellular | No |
Gadoteridol | Prohance | Macrocyclic nonionic | Extracellular | No |
Gadoversetamide | Optimark | Linear nonionic | Extracellular | Yes |
Gadobutrol | Gadavist | Macrocyclic nonionic | Extracellular | No |
Gad oxetate | Eovist | Linear ionic | Hepatobiliary b | No |
Gadofosveset | Ablavar | Macrocyclic albumin bound | Bloodpool c | No |
MRI , Magnetic resonance imaging; NSF , nephrogenic systemic fibrosis.
a Gives general tissue enhanceement.
b Evaluate liver masses.
c Evaluates vasculature.